Wes Kaupinen - Dec 13, 2024 Form 3 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ Kathleen A. McGowan, Attorney-in-Fact
Stock symbol
PVLA
Transactions as of
Dec 13, 2024
Transactions value $
$0
Form type
3
Date filed
12/16/2024, 07:43 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PVLA Common Stock 42.9K Dec 13, 2024 Direct
holding PVLA Common Stock 781K Dec 13, 2024 by Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019
holding PVLA Common Stock 781K Dec 13, 2024 by Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PVLA Stock Option (right to buy) Dec 13, 2024 Common Stock 21.4K $9.79 Direct F1
holding PVLA Stock Option (right to buy) Dec 13, 2024 Common Stock 81.5K $7.53 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in equal monthly installments over a forty-eight month period. The option was granted on February 23, 2023.
F2 The stock option vests in equal monthly installments over a forty-eight month period. The option was granted on May 28, 2024.